Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Neurofibromatosis Type 2
Total 0 results
Nothing found
Sponsors and Collaborators
Canadian National Institute for the Blind
The Urology Foundation, United Kingdom
Alan Prossin
Medicines Development for Global Health
Lanling People's Hospital
UKCCSG United Kingdom
The PLA 940 hospital
Copenhagen University Hospital - Amager and Hvidovre Hospital
The state institution N. N. Alexandrov National Cancer Centre of Belarus
Institute for Exercise and Environmental Medicine
Centro Nacional de Investigacion en Imagenologia e Instrumentacion Medica (CI3M)
Spitalul Universitar de Urgență București
Cardiovascular Research Center, Brazil
Asociación Parkinson Toledo (CAP Toledo)
Dr. Gerard Morton
BioScience Laboratories, Inc.
Research Institute for Biological Safety Problems
University of Chemistry and Technology, Prague
LiNing
InCor Heart Institute
View Full List
Medical Conditions
WHO Grade III or IV Recurrent Glioma
Cancer of Rectum and Anus
Gram-negative Bacterial Infections
Muscle Strength Quantitative Trait Locus 1
Chronic Disease of Musculoskeletal System
Sedation for Non-Emergent Upper and/or Lower Endoscopy
Colon Lesions;
Restless Legs Syndrome, Susceptibility To, 6
Chronic Opioid Therapy
Papules White
Stage IIIB Hepatocellular Carcinoma
Game Addiction, Video
Local Advanced Rectal Cancer
Depressive Mood
Cancer Associated Pain
Giant Cell Arteritis (GCA)
Massage
Pregnancy Nausea and Vomiting
Primary or Secondary Hypogonadism
Bone Marrow Aplasia
View Full List
Drug Interventions
Low dose spironolactone
Rituximab
Prednisolone IF needed
Treatment and prophylaxis
Moxifloxacin
Dexmedetomidine
Tominersen 60 mg
Gemcitabine
Meperidine
Atrasentan
Tramadol
Dinoprostone
Lamivudine
5-Fluorouracil (5-FU)
CBD
I.V drug based multimodal approach
Pertuzumab and Trastuzumab
M9241
Tissue Selective Estrogen Complex
Ranibizumab
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Argentina
Contract Research Organizations in Czech Republic
Contract Research Organizations in Hungary
Contract Research Organizations in Luxembourg
Contract Research Organizations in Mongolia
Contract Research Organizations in Montenegro
Contract Research Organizations in Myanmar
Contract Research Organizations in Panama
Contract Research Organizations in Poland
Contract Research Organizations in Thailand
Contract Research Organizations in Tunisia
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Cameroon
SGS
All CROs in Cameroon
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe